These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2787703)

  • 41. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 43. Complement-dependent induction of DNA synthesis and proliferation of human diploid fibroblasts.
    Korotzer TI; Clagett JA; Kolb WP; Page RC
    J Cell Physiol; 1980 Dec; 105(3):503-12. PubMed ID: 7462337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis.
    Johnson WJ; Bolognesi DP; Adams DO
    Cell Immunol; 1984 Jan; 83(1):170-80. PubMed ID: 6420078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.
    Strife CF; Leahy AE; West CD
    Kidney Int; 1989 Mar; 35(3):836-42. PubMed ID: 2785226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of whole blood antibody dependent cellular cytotoxicity by heat aggregated human IgG.
    MacDonald IM; Dumble LJ; Jack I; Clunie GJ
    J Immunol Methods; 1981; 46(1):69-76. PubMed ID: 7288199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effects of antibodies and complement in macrophage-mediated cytotoxicity on metacercariae of the lung fluke, Paragonimus westermani].
    Min DY; Ahn MH; Kim KM; Leem MH; Park SY
    Kisaengchunghak Chapchi; 1990 Jun; 28(2):91-100. PubMed ID: 2271506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
    McDonald TL
    Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the mechanism of Clq binding to antibody-I. aggregation and/or distortion of IgG vs combining site-transmitted effects.
    Liberti PA; Bausch DM; Schoenberg LM
    Mol Immunol; 1982 Jan; 19(1):143-9. PubMed ID: 6176855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biosynthesis of the complement component C1q in mouse peritoneal macrophage cultures].
    Kulagina NN; Ivanovskaia ND; Taranova IA; Kul'berg AIa
    Biull Eksp Biol Med; 1986 Feb; 101(2):185-7. PubMed ID: 3484977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of immunogenicity and production of ornithine by peritoneal macrophages.
    Kriegbaum H; Benninghoff B; Häcker-Shahin B; Dröge W
    J Immunol; 1987 Aug; 139(3):899-904. PubMed ID: 3110288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin.
    Kawana S; Janson M; Jordon RE
    J Invest Dermatol; 1984 May; 82(5):506-10. PubMed ID: 6439783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The receptor function of C1q, the Fc-recognizing component of the complement system, on macrophages.
    Loos M
    Behring Inst Mitt; 1987 Jun; (81):133. PubMed ID: 3498479
    [No Abstract]   [Full Text] [Related]  

  • 55. Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions.
    Sung SS
    J Immunol; 1985 Sep; 135(3):1981-6. PubMed ID: 4020136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of macrophage antibody-dependent killing of tumor targets by recombinant lymphokine factors and M-CSF.
    Nakoinz I; Ralph P
    Cell Immunol; 1988 Oct; 116(2):331-40. PubMed ID: 2460249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement potentiation of phagocyte-mediated ADCC of HSV-infected corneal cells.
    Adler-Storthz K; Wilson LA; Smith JW
    Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):440-6. PubMed ID: 6706507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cells of the J774 macrophage cell line are primed for antibody-dependent cell-mediated cytotoxicity following exposure to gamma-irradiation.
    Duerst R; Werberig K
    Cell Immunol; 1991 Sep; 136(2):361-72. PubMed ID: 1831405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages.
    Wiltrout RH; Santoni A; Peterson ES; Knott DC; Overton WR; Herberman RB; Holden HT
    J Leukoc Biol; 1985 May; 37(5):597-614. PubMed ID: 3884721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.